We are live on ! Find out more
CMND icon

Clearmind Medicine
CMND

3 hedge funds and large institutions have $12K invested in Clearmind Medicine in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 0.01% → 0.04% (+0.03%)

57% less funds holding

Funds holding: 7 → 3 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

96% less capital invested

Capital invested by funds: $288K → $12K (-$276K)

Holders
3
Holders Change
-4
Holders Change %
-57.14%
% of All Funds
0%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$20.3K
2
JP Morgan Chase
JP Morgan Chase
New York
+$199

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$29K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$24.9K
3
Morgan Stanley
Morgan Stanley
New York
-$2.63K
4
Osaic Holdings
Osaic Holdings
Arizona
-$404
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$387

CMND Hedge Fund Activity: Q4 2025 in Review

3 institutional investors reported a position in Clearmind Medicine (CMND) for Q4 2025, worth a combined $12K — down 96% from $288K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CMND and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was AdvisorShares Investments, adding an estimated $20.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $29K sold.

  • 3 institutional investors held Clearmind Medicine (CMND) as of Q4 2025, down from 7 in Q3 2025.
  • Funds reported $12K of Clearmind Medicine stock for Q4 2025, down 96% quarter-over-quarter.
  • 1 fund opened new Clearmind Medicine positions in Q4 2025 and 5 closed out, a net change of -4 holders.
  • The largest Clearmind Medicine buyer in Q4 2025 was AdvisorShares Investments, an estimated $20.3K added.
  • The largest Clearmind Medicine seller in Q4 2025 was Virtu Financial, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2025.